Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
36.55
-0.09 (-0.25%)
At close: Sep 9, 2025, 4:00 PM
36.59
+0.04 (0.11%)
After-hours: Sep 9, 2025, 4:00 PM EDT
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.84 billion as of September 9, 2025. Its market cap has increased by 3.54% in one year.
Market Cap
1.84B
Enterprise Value
1.40B
1-Year Change
3.54%
Ranking
Category
Stock Price
$36.55
Market Cap Chart
Since the IPO on February 5, 2021, Immunocore Holdings's market cap has increased from $1.08B to $1.84B, an increase of 69.97%. That is a compound annual growth rate of 12.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 1.84B | 24.91% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | 38.39% |
| Feb 5, 2021 | 1.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 673.85B |
| Johnson & Johnson | 426.18B |
| AbbVie | 371.72B |
| UnitedHealth Group | 315.10B |
| AstraZeneca | 251.31B |
| Novartis AG | 248.23B |
| Novo Nordisk | 236.38B |
| Abbott Laboratories | 229.65B |